Key facts
- WearOptimo’s last known valuation is $29.3M (Apr 2025).
- It has raised $8.5M; the latest was Later Stage VC ($7.8M) in Apr 2025.
- Notable investors include Aspen Medical, Australian National University, Brisbane Economic Development Agency, MTPConnect, Rich Lister.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for WearOptimo
- ·The full record, as it builds
Funding rounds
No funding rounds for WearOptimo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About WearOptimo
Developer of diagnostic devices designed for instant diagnosis and monitoring of disorders. The company's wearable device has access to viable epidermis and bio-signals, offering personalized diagnostics across a range of diseases and pain-free health monitoring, enabling individuals to share insights and diagnostics with health professionals and others.
- Sector
- Healthcare
- HQ
- South Brisbane, Australia
- Founded
- 2018
- Employees
- 21
- Website
- wearoptimo.com/
- Ownership
- Privately Held (backing)
WearOptimo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in WearOptimo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on WearOptimo in its N-PORT filings yet. We sweep new filings monthly.